CliffBio
small molecule

CONZIP

TRAMADOL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyCipher →See this company's full patent-cliff portfolio

Drug detail

Brand nameCONZIP
Active ingredientTRAMADOL HYDROCHLORIDE
Strength300MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2010
Marketing statusRX

More from Cipher

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CONZIP patent cliff — loss of exclusivity — | CliffBio